2015 ismrm talk_final
TRANSCRIPT
Three-dimensional Acquisition of Cerebral Blood Volume, Blood Flow, and Blood
Oxygenation-weighted Responses During Functional Stimulation In a Single Scan
Ying Cheng, Qin Qin, Peter C.M. van Zijl, James J. Pekar, and Jun Hua
Speaker Name: Ying Cheng
I have no financial interests or relationships to disclose with regard to the subject matter of this presentation.
Declaration ofFinancial Interests or Relationships
BOLD effect:Blood oxygenation level changeT2* or T2 change
Blood oxygenation level dependent (BOLD) effect
Cerebral blood volume CBV
Cerebral blood flow CBF
Oxygen consumption CMRO2
……
Ogawa et al., PNAS, 1990;87:9868
Quantitative fMRI measurements• Blood-oxygenation-dependent (BOLD)
• Cerebral blood volume (CBV) - vascular-space-occupancy (VASO) MRI
• Cerebral blood flow (CBF)- arterial spin labeling (ASL) MRI
• Using BOLD, CBF, CBV fMRI to estimate oxygen extraction fraction (OEF) and cerebral metabolic rate of O2 (CMRO2) change in the brain
van Zijl et al., Nat Med, 1998;4:159 Davis et al., PNAS, 1998;95:1834Lu H et al., JCBFM, 2004;24: 764
Multimodality hemodynamic response in parenchyma
• blood oxygenation fMRI --- BOLD• cerebral blood volume fMRI --- VASO• cerebral blood flow fMRI --- ASL
Lu, et al JCBFM 24, 764 (2004)
Lu, et al JCBFM 24, 764 (2004)
- Currently each are separately measured- Long scan time, potential problems: head motion, change of physiologic or mental states, etc. - Overall Goal: Develop MRI methods to measure these hemodynamic responses in a time efficient manner
• blood oxygenation fMRI --- BOLD• cerebral blood volume fMRI --- VASO• cerebral blood flow fMRI --- ASL
Multimodality hemodynamic response in parenchyma
Lu et al., MRM 50:263 (2003)
GR
RF
TR
exinversion image
TI
tissueMz/M0
0.2
-1
bloodt
CBV weighted image
VASO MRI Pulse Sequence
TI:inversion time
Non-selective/global
Lu et al., MRM 50:263 (2003)
GR
RF
TR
exinversion image
TI
tissueMz/M0
0.2
-1
bloodt
VASO MRI Pulse Sequence
TI:inversion time
CBV
tissue volume = 1-CBV
Flow-sensitive alternating inversion recovery (FAIR)
• Spatially selective inversion• Imaging after a post-labeling
delay (TI)
label control
FAIR-SS
GR
RF
TR
exinversion
TI
GR
RF
TR
exinversion
TI
TI (1.5-2s)
FAIR-NS
To combine VASO and ASL in one scan
GR
RF
TR
exinversion
TI
GR
RF
TR
exinversion blood
null
TI
FAIR-NS
VASOGR
RF
TR
exinversion FAIR
TI1
exVASO
TI2
The VASO-FAIR pulse sequence
Cheng et al., NeuroImage, 2014;103:533
T2 preparation module to induce the SE-BOLD contrast
3D T2prep-GRE
Hua et al., MRM, 2014;72:1530
T2 preparation module to induce the SE-BOLD contrast3D T2prep-GRE 2D multi-slice SE EPI
Hua et al., MRM, 2014;72:1530
The VASO-FAIR pulse sequence
Adding T2prep BOLD into the VASO-FAIR sequence
Experiments
• 6 healthy volunteers, Philips 3T scanner• fMRI with flashing checkerboard, visual stimulation
• Common imaging parameters: TR = 4s, single-shot 3D fast GRE readout, 16 slices, voxel size = 5x5x5 mm3
• Imaging Sequences (randomized): - Combined VASO-FAIR-BOLD fMRI, TI1/TI2 = 0.6s/1.5s
- Separate VASO fMRI, TI = 0.88s- Separate FAIR-ASL fMRI, TI = 1.5s- Separate 3D T2prep-BOLD fMRI
Averaged fMRI results from the combined sequencen = 6
averaged fMRI results from separate and combined methods
*
*
* P < 0.05
*
Assuming Ya = 0.98, resting Yv = 0.61 (OEFact = 0.38)
resting CBV = 0.052 ml/ml tissue
Quantification of OEF and CMRO2n = 6, STD
ΔCBV(%) ΔCBF(%) Yvact OEFact ΔCMRO2(%)
34.4±4.2 51.2±6.4 0.71±0.01 0.27±0.01 12.6±6.7
Fox PT et al., Science, 1988;241:462Lu H et al., JCBFM, 2004;24:764Donahue et al., JCBFM, 2009;29:1856
Summary
• We designed a 3D combined sequence to monitor whole-brain CBV, CBF, and BOLD responses in a single scan.
• It not only shortened the total scan time, but also reduce the sensitivity to inter-scan variability.
• The proposed method can serve as a more efficient and equally sensitive alternative for quantitative BOLD studies, both task-based and resting-state, where OEF and CMRO2 information can be extracted.
AcknowledgementsPeter Barker, D.Phil.Daniel Herzka, Ph.D.Alan J. Huang, Ph.D.Feng Xu, Ph.D.Xiang Xu, Ph.D.Kannie Chan, Ph.D.Nirhbay Yadav, Ph.D.Xu Li, Ph.D.
Joseph Gillen, B.S.Terri Brawner, B.S., R.T. Kathleen Kahl, R.T. Ivana Kusevic, R.T.
NIH-NIBIB P41-EB015909RO1 EB015032